Current Landscape: Value Assessment Frameworks

How do 7 U.S. value assessment frameworks compare and contrast?

Read our analysis.

COVID-19

NPC member companies are leading efforts in responding to the pandemic.

Learn more.

It's Time to Talk About COVID-19 Prices

Missed the live webinar discussion with health care experts? Watch our video.

View on demand.
Evidence icon

Evidence

How is high-quality, real-world evidence being generated, accepted and used to inform decision-making?
Value icon

Value

Is the value of medicines being recognized as an integral component of care?
Access icon

Access

What can we do to ensure patients have meaningful access to appropriate medications?
Innovation icon

Innovation

How can the health care system support biopharmaceutical innovation that improves patients’ lives?

Featured Content

Research

Improving Patient-reported Measures in Oncology

A white paper from NPC and Discern Health analyzes the landscape of available patient-reported measures and patient-reported performance measures in oncology, and offers recommendations for filling gaps in measures and removing barriers to measure implementation in accountable care programs.

Research

Value Frameworks

Rethinking Our Approach to Value Assessment to Ensure the Patient Voice is Heard

According to a panel that featured NPC Chief Science Officer Robert W. Dubois and was summarized in a Value in Health article, even though value assessment frameworks are growing in use, these cost-effectiveness measurement tools are not ready for “prime time” as they leave out critical considerations, including the patient voice. 

Value Frameworks

Commentary

NPC in Specialty Pharmacy Times: What's Really Behind Discrepancies in Coverage Decisions?

In his latest column for Specialty Pharmacy Times, National Pharmaceutical Council President and CEO Dan Leonard looks at what’s really behind the discrepancies in coverage decisions from one insurer to the next.

 

Commentary